- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.12.25 | Wellgistics Health, Inc.: Wellgistics Health Reminds Shareholders of December 19, 2025 Record Date for Dream Bowl 2026 Meme Coin Tokens | 242 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / December 17, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization... ► Artikel lesen | |
| 16.12.25 | NASDAQ-Rüge für Wellgistics Health: Aktie erfüllt Mindestkursanforderung nicht | 2 | Investing.com Deutsch | ||
| 16.12.25 | Wellgistics Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 08.12.25 | Wellgistics Health, Inc.: Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy to Wellgistics Pharmacy Network | 252 | ACCESS Newswire | Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are uninsured and underinsured and whose out-of-pocket costs exceed Brenzavvy's cash... ► Artikel lesen | |
| 05.12.25 | Wellgistics Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 04.12.25 | Wellgistics sets record date for Dream Bowl 2026 Meme Coin distribution | 1 | Investing.com | ||
| 04.12.25 | Wellgistics Health, Inc.: Wellgistics Health Announces that it will Distribute a Dream Bowl 2026 Meme Coin to Wellgistics Health Stockholders | 281 | ACCESS Newswire | TAMPA, FLORIDA / ACCESS Newswire / December 4, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader implementing EinsteinRx artificial intelligence prescription... ► Artikel lesen | |
| WELLGISTICS HEALTH Aktie jetzt für 0€ handeln | |||||
| 26.11.25 | Wellgistics Health, Inc.: Wellgistics Health Announces Sponsorship of Dream Bowl 2026 and Participation in DataVault AI Dream Bowl 2026 Meme Coin Shareholder Distribution Plan | 653 | ACCESS Newswire | Company plans to distribute Dream Bowl 2026 Meme Coin to shareholders as of a to-be-determined December 2025 date with distribution expected in January 2026 TAMPA, FLORIDA / ACCESS Newswire / November... ► Artikel lesen | |
| 25.11.25 | Datavault AI licenses licenses smart-contract patents to Wellgistics for drug-distribution platform | 3 | Seeking Alpha | ||
| 25.11.25 | DataVault AI licenses smart contracts tech to Wellgistics Health | 2 | Investing.com | ||
| 25.11.25 | Datavault AI Inc.: Datavault AI Licenses Patents Covering Digital Ledger-Enabled Smart Contracts for Commercial Prescription Drug Distribution Industry to Wellgistics Health | 10 | GlobeNewswire (USA) | ||
| 25.11.25 | Wellgistics Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.11.25 | Wellgistics Health GAAP EPS of -$0.46, revenue of $3.01M | 1 | Seeking Alpha | ||
| 20.11.25 | Wellgistics Health, Inc.: Wellgistics Health Reports Third Quarter 2025 Financial Results and Provides Business Update | 415 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / November 20, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader at the nexus of serialization of healthcare technology... ► Artikel lesen | |
| 19.11.25 | Wellgistics Health, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 17.11.25 | Wellgistics Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17.11.25 | Wellgistics Health, Inc.: Wellgistics Health to Report Third Quarter 2025 Financial Results and Provide a Business Update on the morning of Thursday, November 20th, 2025 | 240 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / November 17, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader at the nexus of the physical and technology healthcare... ► Artikel lesen | |
| 14.11.25 | Wellgistics Health, Inc.: Wellgistics Health to Distribute Tollo Health GLP-1 Companion Muscle Loss Medical Food to Pharmacies & Physicians | 243 | ACCESS Newswire | Company to offer the first clinically validated dietary management of sarcopenia, now available for GLP-1 muscle loss, positioning Wellgistics to help 6,500+ independent pharmacy network ('Pharmacy... ► Artikel lesen | |
| 12.11.25 | Wellgistics Health, Inc.: Wellgistics Health Launches EinsteinRx as the Premier AI Prescription Management Hub Solution to Integrate Physical and Technology Healthcare Infrastructure | 289 | ACCESS Newswire | Consolidates messaging around Einstein Rx AI, Wellgistics Hub (formerly DelivMeds) and HubRx AI integration with pharmacies (in-house pharmacy and 6,500+ independent pharmacy network), physicians and... ► Artikel lesen | |
| 04.11.25 | Wellgistics to acquire KareRx in all-stock transaction by January 2026 | 2 | Investing.com |
1 2 3 4 5 Weiter >>
86 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HARROW | 49,000 | 0,00 % | Harrow, Inc.: Harrow Health, Inc. Announces Closing of Acquisition of Melt Pharmaceuticals | NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 6,450 | +1,10 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Broadens Patent Estate for Anaphylm | New patents extend protection for Anaphylm into 2037Anaphylm (dibutepinephrine) Sublingual Film, if approved by the FDA, will be the first and only oral medication for the rescue treatment of severe... ► Artikel lesen | |
| LB PHARMACEUTICALS | 22,250 | +3,49 % | LB Pharmaceuticals Inc: LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer | NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals, Inc ("LB Pharmaceuticals" or the "Company") (Nasdaq: LBRX), a clinical-stage biopharmaceutical company developing novel therapies for... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 16,910 | +0,71 % | Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution) | - NDA assigned a Target Action Date of February 25, 2026 -- Product has patent protection through 2044 - DEER PARK, Ill., July 08, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc ("Eton" or the... ► Artikel lesen | |
| BRIGHT MINDS BIOSCIENCES | 78,26 | +3,18 % | H.C. Wainwright reiterates Buy rating on Bright Minds stock with $115 target | ||
| MILESTONE PHARMACEUTICALS | 2,020 | 0,00 % | Milestone Pharmaceuticals Inc.: Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT) | First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly resolve episodes of PSVT and restore sinus rhythmFDA approval in PSVT enables... ► Artikel lesen | |
| LIPOCINE | 8,030 | +22,22 % | Lipocine Inc.: Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone | Second Drug Safety Monitoring Board (DSMB) meeting update planned for mid-January 2026
Topline results on track for the second quarter of 2026
SALT LAKE CITY... ► Artikel lesen | |
| INTERCURE | 0,910 | -8,36 % | Intercure Ltd. - 6-K, Report of foreign issuer | ||
| INHIBIKASE THERAPEUTICS | 2,050 | +4,06 % | Jefferies reiterates Buy rating on Inhibikase stock, citing faster FDA path | ||
| JOURNEY MEDICAL | 7,710 | +1,18 % | Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights | Third quarter 2025 net revenues were $17.6 million Emrosi total prescriptions increased 146% over the second quarter of 2025 Emrosi net revenues were $4.9 million Company to hold conference call today... ► Artikel lesen | |
| NOVABAY PHARMACEUTICALS | 5,650 | 0,00 % | NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards | EMERYVILLE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces that it has regained compliance with the NYSE American's... ► Artikel lesen | |
| KAZIA THERAPEUTICS | 6,770 | 0,00 % | Kazia Therapeutics Limited: Kazia Therapeutics Regains Full Nasdaq Listing Compliance | Restoration of Nasdaq compliance follows $50 million institutional financing and reinforces balance-sheet strength
SYDNEY, Dec. 22, 2025 /PRNewswire/ -- Kazia Therapeutics... ► Artikel lesen | |
| REVIVA PHARMACEUTICALS | 0,279 | +0,36 % | Reviva Pharmaceuticals: Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum | ||
| OMNIAB | 1,840 | -1,08 % | OmniAb outlines $18M-$22M 2025 revenue guidance while launching OmniUltra and expanding xPloration platform | ||
| VYNE THERAPEUTICS | 0,579 | +2,79 % | VYNE Therapeutics: +167% für den NBC! | Kurz vor Weihnachten ist schon wieder Bescherung im No Brainer Club: VYNE Therapeutics liefert nach einem Top-Deal satte +167% Rendite innerhalb weniger Monate. Die Weihnachtsgeschenke der NBC-Mitglieder... ► Artikel lesen |
Das Unternehmen WELLGISTICS HEALTH INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell +8,71 % bei einem Aktienkurs von 0,400 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WELLGISTICS HEALTH INC finden Sie auf Wallstreet Online.